← Back to all trials
Recruiting
NCT05690347
Protocol for a Multicenter Study on (Cost)Effectiveness of the Back At Work After Surgery (BAAS): a Clinical Pathway for Knee Arthroplasty
Conditions: Arthropathy of Knee
Sex: All
Ages: 18 Years – 65 Years
Enrollment: 150
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Location: Netherlands
Summary
Background Optimizing return to work (RTW) after knee arthroplasty (KA) is becoming increasingly important due to a growing incidence of KA and poor RTW outcomes after KA.
We developed the Back At work After Surgery (BAAS) clinical pathway for optimized RTW after KA.
Since the effectiveness and cost analysis of the BAAS clinical pathway are still unknown, analysis on effectiveness and costs of BAAS is imperative.Method This protocol paper has been written in line with the standards of Standard Protocol Items: Recommendations for Interventional Trails.
To assess the effectiveness and cost-effectiveness for RTW, we will perform a multicenter prospective cohort study with patients who decided to receive a total KA (TKA) or an unicompartmental KA (UKA).
To evaluate the effectiveness of BAAS regarding RTW, a comparison to usual care will be made using individual patient data on RTW from prospectively performed cohort studies in the Netherlands.Discussion One of the strengths of this study is that the feasibility for the BAAS clinical pathway was tested at first hand.
Also, we will use validated questionnaires and functional tests to assess the patient's recovery using robust outcomes.
Moreover, the intervention was performed in two hospitals serving the targeted patient group and to reduce selection bias and improve generalizability.
The limitations of this study protocol are that the lead author has an active role as a medical case manager (MCM) in one of the hospitals.
Additionally, we will use the data from other prospective Dutch cohort studies to compare our findings regarding RTW to usual care.
Since we will not perform an RCT, we will use propensity analysis to reduce the bias due to possible differences between these cohorts.
Eligibility Criteria
nclusion criteria for patients are: (ii) being scheduled for primary or revision UKA or TKA by an orthopedic surgeon between January 2022 and July 2023; (ii) having paid work for at least eight hours a week before surgery; (iii) being between 18 and 65 years of age and (iv) having the intention to fully RTW after surgery.
Criteria to exclude patients are: (i) receiving more than one medical event within one year that affects work ability after KA; (ii) having a KA for any other reason than knee osteoarthritis; and (iii) having major disabling mental disorders.
Patients who do not speak or read Dutch are given the opportunity to fill in the questionnaires with the aid of a translator and to have an interpreter present during the consultations.
Patients who are eligible to participate are informed about the study by telephone by the medical case manager (MCM; physical therapist working in the hospital).
During an intake consultation with an MCM, the patient information letter, informed consent, and an infographic of the BAAS clinical pathway (Appendix I) are handed out to the patient.
Patients' questions regarding participation are answered.
Patients are given one week to decide whether or not they wish to participate.
Patients who opted for the possibility to participate receive a telephone call after one week so that they can ask any additional questions about the study and they will be asked if they want to participate.
Participants willing to participate sign the informed consent.
Source: ClinicalTrials.gov (NCT05690347). StuddyBuddy aggregates publicly available trial information.